Skip To Main Content
Dan Chung on Muck Rack

Dan Chung

As seen in: The Guardian, The Washington Post, The Atlantic, The Toronto Star, TechRadar, Trading View, Dagbladet, New Atlas, Stars and Stripes, GBH News (Boston, MA) and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Dan

Contact Dan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

We Rebuilt After 9/11. The Lessons Still Resonate. — Barrons.com

|
By Dan Chung
| Trading View
At the turn of the millennium, Alger, an investment management firm, was thriving. We had the top-performing fund of the internet era and were growing significantly. Just a few years prior, we had moved into a new office on the 93rd floor of the World Trade Center's North Tower. The office was a great source of pride for our firm and for our CEO and CIO, David Alger. It reflected how far we had come in the 30 or so years since his brother founded the firm.
Open in Who Shared Issue with article?

Nye bilder vekker oppsikt

|
By Lone Gunnerud, Tim Rooke, Dan Chung
| Seher
Hertuginne Sophie (61) pleier sjelden å stjele de største overskriftene i britisk presse. Den britiske kongefamilien har vært preget av skandaler de siste årene; Prins Harrys (41) flukt til USA, den pågående etterforskningen av Andrew Mountbatten-Windsor (66) og prins William (44) og prinsesse Kates (44) hverdag som fremtidig kongepar, stjeler vanligvis oppmerksomheten. I FJOR: Hertuginne Sophie har historisk vært glad i å ha håret oppsatt. Slik så håret hennes ut i 2025.
Open in Who Shared Issue with article?

Ten best practices for developing ophthalmic CGTs

|
By Dan Chung, David Tanzer, Michael Linke
| Cell & Gene Therapy Review Verified
Cell and gene therapies are transformative innovations in ophthalmology, offering the possibility of one-and-done interventions to replace monthly injections for chronic conditions and to target diseases once considered untreatable.
Open in Who Shared Issue with article?
See all 108 licensed articles (118 Total)